KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 17 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $23,822,000 | -40.3% | 29,800,000 | -44.1% | 0.01% | -37.5% |
| Q3 2021 | $39,899,000 | -24.9% | 53,300,000 | 0.0% | 0.01% | -33.3% |
| Q2 2021 | $53,128,000 | +5.4% | 53,300,000 | +10.4% | 0.01% | 0.0% |
| Q1 2021 | $50,405,000 | -7.1% | 48,300,000 | +11.5% | 0.01% | -14.3% |
| Q4 2020 | $54,252,000 | +4.6% | 43,300,000 | 0.0% | 0.01% | -6.7% |
| Q3 2020 | $51,889,000 | +7.4% | 43,300,000 | +26.2% | 0.02% | -11.8% |
| Q2 2020 | $48,314,000 | +16.8% | 34,300,000 | +20.4% | 0.02% | -10.5% |
| Q1 2020 | $41,358,000 | -3.2% | 28,500,000 | -4.2% | 0.02% | 0.0% |
| Q4 2019 | $42,722,000 | – | 29,750,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 20,000,000 | $25,176,000 | 1.70% |
| DeepCurrents Investment Group LLC | 22,530,000 | $28,226,000 | 0.74% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $24,888,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 35,000,000 | $43,527,000 | 0.26% |
| AQR Arbitrage LLC | 4,100,000 | $5,164,000 | 0.18% |
| CSS LLC/IL | 3,000,000 | $3,781,000 | 0.14% |
| Verition Fund Management LLC | 6,579,000 | $8,286,000 | 0.07% |
| LAZARD ASSET MANAGEMENT LLC | 16,500,000 | $20,780,000 | 0.03% |
| Citadel Advisors | 43,300,000 | $54,252,000 | 0.01% |
| CREDIT SUISSE AG/ | 5,017,000 | $6,243,000 | 0.00% |